Incheon, South Korea

Dong-Kyun Ryu

This inventor holds 1 USPTO granted patent. Top assignees: Celltrion Inc., Korea Disease Control and Prevention Agency. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-Kyun Ryu. Retrieved from https://idiyas.com/inventor/dong-kyun-ryu-y15yqf0c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dong-Kyun Ryu: Innovator in SARS-CoV-2 Neutralization

Introduction

Dong-Kyun Ryu is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections. His innovative work focuses on developing solutions to combat SARS-coronavirus-2, the virus responsible for COVID-19.

Latest Patents

Dong-Kyun Ryu holds a patent for a binding molecule that exhibits neutralizing activity against SARS-coronavirus-2. This invention relates to a binding molecule that specifically targets the spike protein on the surface of the virus. The binding molecule demonstrates a strong ability to bind to the spike protein and shows high neutralizing activity, making it a valuable tool for the diagnosis, prevention, or treatment of SARS-coronavirus infection.

Career Highlights

Throughout his career, Dong-Kyun Ryu has worked with notable organizations, including the Korea Disease Control and Prevention Agency and Celltrion Inc. His experience in these institutions has allowed him to contribute to important research and development efforts aimed at addressing public health challenges.

Collaborations

Dong-Kyun Ryu has collaborated with several professionals in his field, including Min-Soo Kim and Han-Saem Lee. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Dong-Kyun Ryu's work in developing a binding molecule against SARS-coronavirus-2 highlights his commitment to advancing medical science and public health. His contributions are crucial in the ongoing battle against COVID-19 and demonstrate the importance of innovation in addressing global health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…